PUBLISHER: Orion Market Research | PRODUCT CODE: 1755413
PUBLISHER: Orion Market Research | PRODUCT CODE: 1755413
Global Artificial Kidney Market Size, Share & Trends Analysis Report by Device Type (Wearable Artificial Kidney and Implantable Artificial Kidney), by Dialysis Type (Hemodialysis and Peritoneal Dialysis), and by End-User (Dialysis Centers, Specialty Clinics, and Hospitals), Forecast Period (2025-2035)
Artificial kidney market is anticipated to grow at a considerable CAGR of 15.0% during the forecast period. The market is growing owing to the rising incidence of chronic kidney diseases, a shortage of donors, and advancements in artificial kidney technology. The increasing global number of people suffering from diseases such as Acquired Cystic Kidney Disease, Glomerular Diseases, Diabetes Insipidus, and others is driving market expansion. Furthermore, the scarcity of kidney donors is a major driver accelerating market growth. For instance, in June 2021, the US Department of Health and Human Services (HHS) collaborated with the American Society of Nephrology (ASN) to drive innovation in kidney disease prevention, diagnosis, and treatment. Currently, these groups are collaborating to develop waterless, dialysate-free technology, which will aid in the creation of the first implantable prosthetic kidney by 2026.
The global artificial kidney market is segmented based on its device type, dialysis type, and end-user. Based on device type, the market is bifurcated into wearable artificial kidneys and implantable artificial kidneys. Based on dialysis type, the market is segmented into hemodialysis and peritoneal dialysis. Further, based on the end-user, the market is sub-segmented into dialysis centers, specialty clinics, and hospitals. Among the end-users, the hospitals sub-segment is anticipated to have a significant market share owing to the expansion of kidney disease-related healthcare facilities and hospitals across the globe.
The sub-segment of the wearable artificial kidney is expected to grow in the artificial kidney market. The market growth is driven by the increasing demand for portable and user-friendly dialysis solutions that offer patients greater convenience compared to traditional solutions. Wearable artificial kidney aims to provide effective and continuous dialysis that reduces the frequent visits to dialysis centers. In addition, advances in miniaturization, biocompatible materials, and battery efficiency are making these devices more commercially practical. The rising prevalence of chronic kidney disease (CKD) and the preference for home-based treatment alternatives are fueling the development of wearable artificial kidneys, making this category a key market driver.
The global artificial kidney market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). Among these, the European region is anticipated to grow at a considerable rate in the artificial kidney market during the forecast period, owing to the increasing healthcare expenditure coupled with the rising prevalence of kidney diseases.
The North American region is expected to grow significantly in the artificial kidney market during the forecast period. The primary factors that drive the market continuously include the high frequency of chronic renal disease and kidney cancer and a well-developed healthcare center. Furthermore, the strong presence of leading market players in the region, combined with different strategic initiatives by industry leaders, is likely to drive regional market growth. The rising prevalence of renal illnesses, which can result in kidney damage or failure, is expected to raise demand for artificial kidneys. Furthermore, in August 2022, the American Society of Nephrology (ASN) and the US Department of Health and Human Services (HHS) announced Kidney's new prize competition, also the launch of a new artificial kidney reward with millions in funding. Thus, the region's increasing funding activities for artificial kidneys are expected to drive growth in the approaching years.
The major companies serving the global artificial kidney market include B. Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, Nikkiso Co. Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.
Recent Developments